Posted by Michael Wonder on 06 Apr 2021
Biofrontera submits application for FDA approval of new BF-RhodoLED XL lamp
31 March 2021 - Biofrontera today announced the submission for approval of a new, significantly larger red-light source for photodynamic therapy to be used in combination with Ameluz, the BF-RhodoLED XL, to the U.S. FDA.
The new BF-RhodoLED XL is to be approved in combination with Ameluz for the treatment of mild and moderate actinic keratoses on the face and scalp.
